Pandemic response using Moderna’s mRNA platform technology
Darin Edwards, Ph.D
Tuesday, September 15, 2020, at 7 p.m. virtual presentation via BlueJeans
Dr. Edwards will discuss:
- Moderna’s mRNA platform technology
- How the development of that technology has enabled fast response to pandemic threats
- Background on SARS-CoV-2 and the current pandemic
- Moderna’s SARS-CoV-2 vaccine program and description of their response to the pandemic
Darin Edwards currently leads the research group that has developed and evaluated Moderna’s SARS-CoV-2 mRNA-1273 vaccine. Prior to joining Moderna, he was at Sanofi Pasteur where he spent close to a decade working to develop vaccines against infectious diseases, including influenza, dengue, and yellow fever.